Institute for Aging Research, Hebrew SeniorLife, Boston, MA, USA.
Department of Medicine, Harvard Medical School, Boston, MA, USA.
J Bone Miner Res. 2018 Jan;33(1):54-62. doi: 10.1002/jbmr.3240. Epub 2017 Sep 20.
Older adults with type 2 diabetes (T2D) tend to have normal or greater areal bone mineral density (aBMD), as measured by DXA, than those who do not have diabetes (non-T2D). Yet risk of fracture is higher in T2D, including 40% to 50% increased hip fracture risk. We used HR-pQCT to investigate structural mechanisms underlying skeletal fragility in T2D. We compared cortical and trabecular bone microarchitecture, density, bone area, and strength in T2D and non-T2D. In secondary analyses we evaluated whether associations between T2D and bone measures differed according to prior fracture, sex, and obesity. Participants included 1069 members of the Framingham Study, who attended examinations in 2005 to 2008 and underwent HR-pQCT scanning in 2012 to 2015. Mean age was 64 ± 8 years (range, 40 to 87 years), and 12% (n = 129) had T2D. After adjustment for age, sex, weight, and height, T2D had lower cortical volumetric BMD (vBMD) (p < 0.01), higher cortical porosity (p = 0.02), and smaller cross-sectional area (p = 0.04) at the tibia, but not radius. Trabecular indices were similar or more favorable in T2D than non-T2D. Associations between T2D and bone measures did not differ according to sex or obesity status (all interaction p > 0.05); however, associations did differ in those with a prior fracture and those with no history of fracture. Specifically, cortical vBMD at the tibia and cortical thickness at the radius were lower in T2D than non-T2D, but only among those individuals with a prior fracture. Cortical porosity at the radius was higher in T2D than non-T2D, but only among those who did not have a prior fracture. Findings from this large, community-based study of older adults suggest that modest deterioration in cortical bone and reductions in bone area may characterize diabetic bone disease in older adults. Evaluation of these deficits as predictors of fracture in T2D is needed to develop prevention strategies in this rapidly increasing population of older adults. © 2017 American Society for Bone and Mineral Research.
2 型糖尿病(T2D)老年患者的骨密度(aBMD)通常与非糖尿病患者(非 T2D)相同或更高,这是通过 DXA 测量得出的。然而,T2D 患者的骨折风险更高,包括髋部骨折风险增加 40%至 50%。我们使用 HR-pQCT 研究了 T2D 患者骨骼脆弱的结构机制。我们比较了 T2D 和非 T2D 患者的皮质骨和小梁骨微结构、密度、骨面积和强度。在次要分析中,我们评估了 T2D 与骨量之间的关联是否因既往骨折、性别和肥胖而有所不同。参与者包括 1069 名弗雷明汉研究的成员,他们于 2005 年至 2008 年接受检查,并于 2012 年至 2015 年接受 HR-pQCT 扫描。平均年龄为 64±8 岁(范围,40 至 87 岁),12%(n=129)患有 T2D。调整年龄、性别、体重和身高后,T2D 患者的胫骨皮质体积 BMD(vBMD)较低(p<0.01),皮质孔隙率较高(p=0.02),横截面积较小(p=0.04),但桡骨无差异。T2D 患者的小梁指数与非 T2D 患者相似或更有利。T2D 与骨量之间的关联不因性别或肥胖状态而异(所有交互 p>0.05);然而,在有既往骨折和无既往骨折的患者中,关联确实不同。具体而言,胫骨的皮质 vBMD 和桡骨的皮质厚度在 T2D 中低于非 T2D,但仅在有既往骨折的患者中如此。桡骨的皮质孔隙率在 T2D 中高于非 T2D,但仅在无既往骨折的患者中如此。这项针对老年社区人群的大型研究结果表明,皮质骨的适度恶化和骨面积的减少可能是老年糖尿病患者的特征。评估这些缺陷是否可作为 T2D 骨折的预测因子,对于这一迅速增加的老年人群的预防策略非常重要。 © 2017 美国骨骼与矿物质研究协会。